Boardroom Alpha
Boardroom Alpha
HLF · Additional Proxy Materials (DEFA14A) · Filed March 17, 2026

Herbalife Ltd — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
March 17, 2026
Ticker
HLF
Accession
0001213900-26-029134
Boardroom Alpha · Filing insights

No material developments for governance. Herbalife Ltd.'s annual meeting includes a standard director slate and advisory votes.

About Herbalife Ltd
Market cap
$1.2B
1Y TSR
+66.5%
3Y TSR
+2.3%
Board grade
C
Sector
Consumer Defensive
CEO
Stephan Paulo Gratziani
Last annual meeting: Apr 30, 2026 · View full Herbalife Ltd profile →

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

____________________________________

SCHEDULE 14A

____________________________________

PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO.    )

Filed by the Registrant

 

 

Filed by a Party other than the Registrant

 

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material under §240.14a-12

HERBALIFE LTD.
(Name of Registrant as Specified In Its Charter)

______________________________________________________________________________

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

 

No fee required.

 

Fee paid previously with preliminary materials.

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

Your Vote Counts! HERBALIFE LTD. 2026 Annual Meeting Vote by April 29, 2026 11:59 PM ET You invested in HERBALIFE LTD. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the shareholder meeting to be held on April 30, 2026. Get informed before you vote View the Annual Report, Notice & Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 05, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Point your camera here and vote without entering a control number Vote in Person at the Meeting* April 30, 2026 8:30 AM PDT 800 W. Olympic Blvd. Suite 406 Los Angeles, CA 90015 and Virtually at: meetnow.global/MMVF2KX *If you choose to vote these shares in person at the meeting, you must request a “legal proxy.” To do so, please follow the instructions at www.ProxyVote.com or request a paper copy of the materials, which will contain the appropriate instructions. Please check the meeting materials for any special requirements for meeting attendance.

 

Vote at www.ProxyVote.com Control # THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. HERBALIFE LTD. 2026 Annual Meeting Vote by April 29, 2026 11:59 PM ET Voting Items Board Recommends 1. Election of Directors Nominees: 1A Richard H. Carmona For 1B Lynda Cloud For 1C Sophie L’Hélias For 1D Michael O. Johnson For 1E Michael J. Levitt For 1F Rodica Macadrai For 1G Perkins Miller For 1H Juan Miguel Mendoza For 1I Don Mulligan For 1J Maria Otero For 1K Des Walsh For 2. Approve, on an advisory basis, the compensation of the Company’s named executive officers For 3. Ratify, on an advisory basis, the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2026 For NOTE: Such other business as may properly come before the meeting or any adjournment thereof. Under New York Stock Exchange rules, brokers may vote “routine” matters at their discretion if your voting instructions are not communicated to us at least 10 days before the meeting. We will nevertheless follow your instructions, even if the broker’s discretionary vote has already been given, provided your instructions are received prior to the meeting date.

 

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Herbalife Ltd (HLF)

Reference

Frequently asked questions

When did Herbalife Ltd file this DEFA14A?
Herbalife Ltd (HLF) filed this Additional Proxy Materials (DEFA14A) with the SEC on March 17, 2026. The accession number assigned by EDGAR is 0001213900-26-029134.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
No material developments for governance. Herbalife Ltd.'s annual meeting includes a standard director slate and advisory votes. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Herbalife Ltd's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Herbalife Ltd has filed under CIK 1180262, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer